The GLP is committed to full transparency. Download and review our 2019 Annual Report

Podcast: A closer look at the CRISPR experiment that could cure sickle cell disease

, | | December 9, 2019
crispr gray july enl ae f d c cb bbaecfc f e x
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Victoria Gray has sickle cell disease, a painful and debilitating genetic condition that affects millions of people around the world. But an experimental gene-editing technique known as CRISPR could help her — and, if it does, change the way many genetic diseases are treated. Correspondent Rob Stein tells her story, an NPR-exclusive.

“It is kind of amazing to think about that if this treatment is successful, there could be a time in the future when these types of debilitating genetic diseases could just be edited out,” said host Maddie Sofia.

Read full, original post: A Revolutionary Experiment To Edit Human Genes

Related article:  Viewpoint: Arrival of GMO, gene-edited biofortified crops weakens case for organic agriculture
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend